Insider trades

Posard Matthew L.

Posard Matthew L. made 0 buys and 8 sales on the open market in the last 12 months at Halozyme Therapeutics, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Oct 1, 2026Halozyme Therapeutics, Inc.Sale730US$107
Oct 1, 2026Halozyme Therapeutics, Inc.Sale3,300US$108
Oct 1, 2026Halozyme Therapeutics, Inc.Sale1,100US$110
Oct 1, 2026Halozyme Therapeutics, Inc.Sale100US$110
Sep 16, 2026Halozyme Therapeutics, Inc.Sale3,000US$107
Sep 16, 2026Halozyme Therapeutics, Inc.Sale8,896US$108
Sep 16, 2026Halozyme Therapeutics, Inc.Sale3,100US$106
Sep 16, 2026Halozyme Therapeutics, Inc.Sale4,000US$109